Publisher Correction: GLS-409, an Antagonist of Both P2Y<sub>1</sub> and P2Y<sub>12</sub>, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation.

Smolensky Koganov, Elena; Michelson, Alan D; Yanachkov, Ivan B; Yanachkova, Milka I; Wright, George E; Przyklenk, Karin; Frelinger, Andrew L

Publisher Correction: GLS-409, an Antagonist of Both P2Y₁ and P2Y₁₂, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation.

Smolensky Koganov, Elena; Michelson, Alan D; Yanachkov, Ivan B; Yanachkova, Milka I; Wright, George E; Przyklenk, Karin; Frelinger, Andrew L.

Afiliação

Smolensky Koganov E; Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
Michelson AD; Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
Yanachkov IB; GLSynthesis Inc., Worcester, MA, USA.
Yanachkova MI; GLSynthesis Inc., Worcester, MA, USA.
Wright GE; GLSynthesis Inc., Worcester, MA, USA.
Przyklenk K; Cardiovascular Research Institute and Departments of Physiology and Emergency Medicine, Wayne State University School of Medicine, Detroit, MI, USA.
Frelinger AL; Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA. Andrew.Frelinger@childrens.harvard.edu.

Sci Rep ; 8(1): 17580, 2018 Nov 29.

Article em En | MEDLINE | ID: mdl-30498241

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google